Riboswitches as antibacterial drug targets
Top Cited Papers
- 11 December 2006
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (12) , 1558-1564
- https://doi.org/10.1038/nbt1268
Abstract
New validated cellular targets are needed to reinvigorate antibacterial drug discovery. This need could potentially be filled by riboswitches—messenger RNA (mRNA) structures that regulate gene expression in bacteria. Riboswitches are unique among RNAs that serve as drug targets in that they have evolved to form structured and highly selective receptors for small drug-like metabolites. In most cases, metabolite binding to the receptor represses the expression of the gene(s) encoded by the mRNA. If a new metabolite analog were designed that binds to the receptor, the gene(s) regulated by that riboswitch could be repressed, with a potentially lethal effect to the bacteria. Recent work suggests that certain antibacterial compounds discovered decades ago function at least in part by targeting riboswitches. Herein we will summarize the experiments validating riboswitches as drug targets, describe the existing technology for riboswitch drug discovery and discuss the challenges that may face riboswitch drug discoverers.Keywords
This publication has 59 references indexed in Scilit:
- Structure of the S-adenosylmethionine riboswitch regulatory mRNA elementNature, 2006
- Identification of a Mutation in the Bacillus subtilis S -Adenosylmethionine Synthetase Gene That Results in Derepression of S-Box Gene ExpressionJournal of Bacteriology, 2006
- High‐Throughput‐Compatible Assay for glmS Riboswitch Metabolite DependenceChemBioChem, 2006
- Sampling the Antibiotic ResistomeScience, 2006
- RNA as a target for small-molecule therapeuticsExpert Opinion on Therapeutic Patents, 2005
- On the structural basis of peptide‐bond formation and antibiotic resistance from atomic structures of the large ribosomal subunitFEBS Letters, 2004
- An mRNA structure that controls gene expression by binding S-adenosylmethionineNature Structural & Molecular Biology, 2003
- Fine-structure mapping ofcis-acting control sites in thelysCoperon ofBacillus subtilisFEMS Microbiology Letters, 1992
- The mode of action of pyrithiamine as an inductor of thiamine deficiencyBiochimica et Biophysica Acta, 1958
- DL-4-Oxalysine, an Inhibitory Analog of LysineJournal of the American Chemical Society, 1957